WO2011094504A4 - Antimicrobial sinus irrigation compositions, methods, and devices - Google Patents
Antimicrobial sinus irrigation compositions, methods, and devices Download PDFInfo
- Publication number
- WO2011094504A4 WO2011094504A4 PCT/US2011/022874 US2011022874W WO2011094504A4 WO 2011094504 A4 WO2011094504 A4 WO 2011094504A4 US 2011022874 W US2011022874 W US 2011022874W WO 2011094504 A4 WO2011094504 A4 WO 2011094504A4
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agent
- antimicrobial
- nasal irrigation
- irrigation fluid
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0279—Cannula; Nozzles; Tips; their connection means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
- A61M3/0245—Containers therefor, e.g. with heating means or with storage means for cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
- A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
- A61M3/0262—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped manually, e.g. by squeezing a bulb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/20—Pathogenic agents
- A61M2202/203—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0681—Sinus (maxillaris)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
This application discloses topical sinus irrigation formulations, uses thereof, and delivery devices thereof.
Claims
1. A single-use nasal irrigation delivery device comprising;
a single-use reservoir and an irrigator tip, wherein the single-use reservoir is configured for controlled collapsing to dispense nasal irrigation fluid from the reservoir through a reservoir outlet at the irrigator tip, wherein the irrigator tip is configured to create a seal to the nostril in order to direct a stream of antimicrobial fluid into the sinuses.
2. The single-use nasal irrigation delivery device of claim 1 , wherein the reservoir has a volume capacity of from about 1 ml to about 500 ml.
3. The single-use nasal irrigation delivery device of claim 1 , wherein the irrigator tip has an extension so that the intranasal release of liquid occurs more proximal to the sinuses than with traditional sinus rinse bottles.
4. The single-use nasal irrigation delivery device of claim 1 , wherein the reservoir is shaped like a bellows to allow for controlled collapsing and for the expulsion of the total liquid volume contained in the device without the need for a Straw.
5. The single-use nasal irrigation delivery device of claim 1 , wherein the device is
manufactured so that its liquid contents are sterile.
6. The single-use nasal irrigation delivery device of claim 1 , wherein the device contains a substance comprising one or more pharmaceutical substances selected from the group consisting of an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, an anti-inflammatory agent (e.g., non-steroidal anti-inflammatory (NSAID) or
corticosteroid), or any combination or mixture thereof,
7. The single-use nasal irrigation delivery device of any one of claims 1 to 5 or any combination of claims 1 to 5, wherein the reservoir contains an antimicrobial nasal irrigation fluid useful for treatment of sinusitis, wherein the antimicrobial nasal irrigation fluid comprises an antimicrobial agent in a therapeutically effective amount, a buffered isotonic, hypertonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, a flavoring agents and fragrances.
8. An antimicrobial nasal irrigation fluid useful for treatment of sinusitis, comprising:
an antimicrobial agent in a therapeutically effective amount, a buffered isotonic, hypotonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, flavoring agents and fragrances.
9. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent is selected from the group consisting of cephalosporins, penicillins, penicillins, beta lactamase inhibitors, carbepenems, monobactams, macrolides, lincosamines, lipopeptide,
glycopeptides, lipoglycopeptides, carbapenem, rifampin, oxazolidonones, tetracyclines, aminoglycosides, streptogramins, and sulfonamides and combinations thereof.
10. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent is a
quinolone, fluoroquinolone, heteroaryl isothiazolone, or a isothiazoloquinolone,
1 1. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent is
levofloxacin.
12. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent has a concentration from about 0.1% to about 30%.
13. The antimicrobial nasal irrigation fluid of any one of claims 7 to 12, further comprising one or more pharmaceutical substances selected from the group consisting of an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, an anti-inflammatory agent (e.g., non-steroidal anti-inflammatory (NSAID) οτ corticosteroid), or any combination or mixture thereof.
14. A method of treating a patient with sinusitis comprising intranasally administering to said patient a therapeutically effective amount of the antimicrobial nasal irrigation fluid of any one of claims 7 to 13 using the device of any one of claims 1 to 5 or any combinations of claims 1 to 5.
15. The method of claim 14, wherein the sinusitis is the result of microbial infection.
16. The method of claim 14, wherein the sinusitis is the result of bacterial infection.
17. A nasal irrigation fluid useful for treatment of a medical condition of the sinonasal tract, comprising: one or more pharmaceutical substances selected from the group consisting of an antimicrobial, an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, a fibrotic agent, an anti-inflammatory agent {e.g., non-steroidal anti-inflammatory (NSAID) or corticosteroid), a pro-coagulant agent, an anti-fibrotic agent, an anti -metabolite agent, an anti-cancer agent, a surfactant or any combination or mixture thereof in a therapeutically effective amount, a buffered isotonic, hypotonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, flavoring agents and fragrances.
18. A method of treating a patient with a medical condition of the sinonasal tract comprising intranasally administering to said patient a therapeutically effective amount of the nasal irrigation fluid of claim 17.
19. A method of treating a patient with a medical condition of the sinonasal tract comprising intranasally administering to said patient a therapeutically effective amount of the nasal irrigation fluid of claim 18 using the device of any one of claims 1 to 5 or any combination of claims 1 to 5.
20. The single-use nasal irrigation delivery device of any one of claims 1 to 5 or any combination of claims 1 to 5, wherein the reservoir contains a nasal irrigation fluid useful for treatment of a medical condition of the sinonasal tract, comprising: one or more pharmaceutical substances selected from the group consisting of an antimicrobial, an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, a fibrotic agent, an anti-inflammatory agent (e.g., non-steroidal anti-inflammatory (NSAID) or corticosteroid), a pro-coagulant agent, an anti-fibrotic agent, an anti-metabolite agent, an anti-cancer agent, a surfactant or any combination or mixture thereof in a therapeutically effective amount, a buffered isotonic, hypotonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, flavoring agents and fragrances.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29905110P | 2010-01-28 | 2010-01-28 | |
US61/299,051 | 2010-01-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2011094504A2 WO2011094504A2 (en) | 2011-08-04 |
WO2011094504A3 WO2011094504A3 (en) | 2011-12-29 |
WO2011094504A4 true WO2011094504A4 (en) | 2012-02-16 |
Family
ID=44320139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/022874 WO2011094504A2 (en) | 2010-01-28 | 2011-01-28 | Antimicrobial sinus irrigation compositions, methods, and devices |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011094504A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017313532A1 (en) * | 2016-08-15 | 2019-03-07 | Rhinoclear Nasal Care Solutions Inc. | Nasal irrigation apparatus and kit |
US20180071281A1 (en) * | 2016-08-19 | 2018-03-15 | Gerbe Labs Inc. | Treating chronic rhinosinusitis |
US10420776B2 (en) * | 2016-10-13 | 2019-09-24 | RhinoNase, Inc. | Antibiotic compositions for nasal irrigation and methods |
US20210330584A1 (en) * | 2020-04-22 | 2021-10-28 | Topical Sinus Therapeutics, Inc. | Topical preparations of drug delivery for nasal and sinus irrigation |
MX2023007926A (en) * | 2020-12-31 | 2023-10-12 | Ntby Moss Llc | Formulations of a prophylactic nasal spray and methods of use and manufacture thereof. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2367756B (en) * | 2000-10-12 | 2003-01-08 | Bespak Plc | Dispensing apparatus |
WO2002041837A2 (en) * | 2000-11-22 | 2002-05-30 | Rxkinetix, Inc. | Treatment of mucositis |
GB0215904D0 (en) * | 2002-07-09 | 2002-08-21 | Team Holdings Uk Ltd | Drug delivery system and method |
US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
-
2011
- 2011-01-28 WO PCT/US2011/022874 patent/WO2011094504A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011094504A3 (en) | 2011-12-29 |
WO2011094504A2 (en) | 2011-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11723859B2 (en) | Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity | |
WO2011094504A4 (en) | Antimicrobial sinus irrigation compositions, methods, and devices | |
WO2003020219B1 (en) | Aerosolized decongestants for the treatment of sinusitis | |
US20160166505A1 (en) | Methods And Compositions For Treatment Of Respiratory Tract Infections | |
JP2013524960A (en) | Method for operating aerosol delivery device and aerosol delivery device | |
MX2008010351A (en) | Pharmaceutical formulations. | |
JP2011520894A5 (en) | ||
WO2007112274A3 (en) | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin | |
RS54438B1 (en) | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine | |
US20220160677A1 (en) | Tumescent infiltration drug delivery of cannabinoids | |
US20160279057A1 (en) | Azelastine Formulations For Intranasal Nebulization And Irrigation | |
JP2022525762A (en) | Materials and methods to enhance the treatment and prevention of biofilm formation | |
KR20150012305A (en) | catheter for photodynamic therapy | |
US20160022595A1 (en) | Bioadhesive and biodegradable and formulations that provide sustained release of antimicrobials, bacteriophages and anti-inflammatory medications for inactivation of biofilms and the treatment of rhinosinusitis and other infections | |
US20180071281A1 (en) | Treating chronic rhinosinusitis | |
US10493218B2 (en) | Device for delivery of an aerosol substance | |
US20160317546A1 (en) | Method for treating otic infections after tympanostomy tube placement | |
WO2021216915A1 (en) | Topical preparations of drug delivery for nasal and sinus irrigation | |
JP2019516797A5 (en) | ||
WO2020160328A1 (en) | Tumescent infiltration drug delivery of cannabinoids | |
JP2016527322A5 (en) | ||
CN205460414U (en) | Soft pipe of spraying in air flue | |
Kumar | Topical Management of Chronic Rhinosinusitis | |
US20240148776A1 (en) | Tumescent solution with b vitamins | |
CN203107976U (en) | Double-end treatment tube used in medical oncology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11737707 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11737707 Country of ref document: EP Kind code of ref document: A2 |